ADCT Stock Analysis: Buy, Sell, or Hold?
ADCT - ADC Therapeutics SA
$1.19
0.05 (4.39%)
▲
5d:
+14.42%
30d:
-62.46%
90d:
-68.68%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When ADCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ADCT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ADCT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ADCT is currently trading at $1.19, which is considered fair relative to its 30-day fair value range of $0.67 to $2.67.
Technical Outlook: Technically, ADCT is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.23. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: ADCT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+320.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ADCT is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.23. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: ADCT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+320.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.67 -
$2.67
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 320.2% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$0.67 -
$2.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.00
Resistance Level
$1.23
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.80
Wall Street Target
$5.00
(+320.2%)
Revenue Growth (YoY)
-9.5%
Profit Margin
-173.0%
Share & Embed Analysis
Last updated: July 04, 2026 1:02 AM ET
Data refreshes hourly during market hours. Next update: 2:02 AM
Data refreshes hourly during market hours. Next update: 2:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Redmile Group, Llc
SELL
2529491 shares
2026-04-02
Redmile Group, Llc
SELL
2634506 shares
2026-04-02
Redmile Group, Llc
SELL
162517 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
